BIOMAT Database Logo BIOMAT Database Logo

A new antibiotic, cypemycin. Taxonomy, fermentation, isolation and biological characteristics. 1993

K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Kitasato Institute, Tokyo, Japan.

A new peptide antibiotic, cypemycin, with a molecular weight of 2,097 (M+H), was isolated from the culture broth of Streptomyces sp. OH-4156. The antibiotic possesses cytocidal activity against P388 leukemia cells in vitro at a concentration of 1.3 microgram/ml (IC50 values), and the antibiotic showed antimicrobial activities against Micrococcus luteus (MIC, 0.2 microgram/ml).

UI MeSH Term Description Entries
D007941 Leukemia P388 An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene. P388D(1) Leukemia,P388, Leukemia
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D005285 Fermentation Anaerobic degradation of GLUCOSE or other organic nutrients to gain energy in the form of ATP. End products vary depending on organisms, substrates, and enzymatic pathways. Common fermentation products include ETHANOL and LACTIC ACID. Fermentations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000903 Antibiotics, Antineoplastic Chemical substances, produced by microorganisms, inhibiting or preventing the proliferation of neoplasms. Antineoplastic Antibiotics,Cytotoxic Antibiotics,Antibiotics, Cytotoxic

Related Publications

K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
A new antibiotic, okicenone. I. Taxonomy, fermentation, isolation and biological characteristics.
August 1991, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Butalactin, a new butanolide antibiotic. Taxonomy, fermentation, isolation and biological activity.
February 1991, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
A novel antibiotic, sohbumycin. Taxonomy, fermentation, isolation and physico-chemical and biological characteristics.
August 1985, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Thrazarine, a new antitumor antibiotic. I. Taxonomy, fermentation, isolation and biological properties.
November 1988, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Pyrroxamycin, a new antibiotic taxonomy, fermentation, isolation, structure determination and biological properties.
July 1987, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Reductiomycin, a new antibiotic. I. Taxonomy, fermentation, isolation, characterization and biological activities.
June 1981, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Proticin, a new phosphorus-containing antibiotic. I. Taxonomy, fermentation, isolation, and biological properties.
January 1972, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Studies on a novel antitumor antibiotic, phenazinomycin: taxonomy, fermentation, isolation, and physicochemical and biological characteristics.
July 1989, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Mutalomycin, a new polyether antibiotic taxonomy, fermentation, isolation and characterization.
November 1977, The Journal of antibiotics,
K Komiyama, and K Otoguro, and T Segawa, and K Shiomi, and H Yang, and Y Takahashi, and M Hayashi, and T Otani, and S Omura
Capuramycin, a new nucleoside antibiotic. Taxonomy, fermentation, isolation and characterization.
August 1986, The Journal of antibiotics,
Copied contents to your clipboard!